Breaking News: What You’re Itching to Know About Primary Biliary Cholangitis and Pruritus

overview

Primary biliary cholangitis (PBC) is an underdiagnosed, progressive autoimmune liver disease that if left untreated can result in liver failure, necessitating transplantation, and death. Pruritus is one of the most common and debilitating symptoms of PBC and can severely impair patients’ quality of life. In this newscast-style live town hall, expert faculty will discuss the latest clinical evidence for the management of PBC and PBC-associated pruritus, including breaking news on novel therapies that target key pathways in PBC pathogenesis. Attendees will hear from a real patient who will relate their experience living with PBC. A professional host will engage the audience and faculty and facilitate an interactive, fun, and informative newscast-style experience. Join us and scratch your itch to know more about PBC!

This program is not affiliated with Digestive Disease Week®.

faculty

Steven Flamm, MD, FAASLD, FACG

Professor, Department of Internal Medicine

Division of Digestive Diseases and Nutrition, RUSH Medical College

Clinical Director of Network Development and Outreach, Transplant Service Line

Director of Research, Section of Hepatology

Chicago, Illinois, United States

Sonal Kumar, MD, MPH

Director, General Gastroenterology and Hepatology

Director, Innovative Center for Health and Nutrition in Gastroenterology (ICHANGE)

Assistant Professor of Medicine

Weill Cornell Medical College

New York, New York, United States

Mo Christie

Head of Patient Services

PBC Foundation

Dunfermline, United Kingdom

Taryn Winter Brill

Medical Journalist

AGENDA

6:30 PM TZ

Welcome and Introduction

6:35 PM TZ

Segment 1: Breaking News on Treatments for PBC

6:50 PM TZ

Segment 2: The Patient Viewpoint: Living with PBC-Associated Pruritus

6:55 PM TZ

Audience Perspectives on Patient Viewpoint

7:00 PM TZ

Segment 3: Current Concepts in Assessing and Managing PBC-Associated Pruritus

7:15 PM TZ

Audience Perspectives on Itch

7:25 PM TZ

Segment 4: Case Discussions

7:40 PM TZ

Ask the Experts: Audience Q&A

7:45 PM TZ

Program Conclusion

TARGET AUDIENCE

This educational activity is intended for an audience of gastroenterologists, hepatologists, primary care physicians, nurse practitioners, physician assistants and nurses in the United States.

GOAL STATEMENT

The goal of this activity is for learners to be better able to recognize the burden and impact of PBC-associated pruritus and make evidence-based treatment recommendations.

LEARNING OBJECTIVES

Upon completion of this activity, participants will: [break] Have increased knowledge regarding the:[list][item]Patient burden of PBC-associated pruritus[item]Clinical data on pruritus-related outcomes from clinical trials of PBC treatments[/list] [break] Have greater competence related to:[list][item]Assessing PBC-related pruritus in clinical practice[/list]

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

[bold]For Physicians[/bold] [break] Medscape, LLC designates this live activity for a maximum of 1.25 [italic][bold]AMA PRA Category 1 Credits[/bold][/italic]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [break] [bold]For Nurses[/bold] [break] Awarded 1.25 contact hour(s) of nursing continuing professional development for RNs and APNs.

CME/CNE